Search results for "ToP"

showing 10 items of 17685 documents

Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo.

2011

Identification of physiologically relevant substrates is still the most challenging part in protease research for understanding the biological activity of these enzymes. The zinc-dependent metalloprotease meprin β is known to be expressed in many tissues with functions in health and disease. Here, we demonstrate unique interactions between meprin β and the amyloid precursor protein (APP). Although APP is intensively studied as a ubiquitously expressed cell surface protein, which is involved in Alzheimer disease, its precise physiological role and relevance remain elusive. Based on a novel proteomics technique termed terminal amine isotopic labeling of substrates (TAILS), APP was identified …

medicine.medical_treatmentBiologyProteomicsBiochemistryPolymerase Chain ReactionCell LineSubstrate Specificity03 medical and health sciencesAmyloid beta-Protein PrecursorMice0302 clinical medicinemental disordersAmyloid precursor proteinmedicineAnimalsHumansProtein IsoformsMolecular Biology030304 developmental biologyDNA Primerschemistry.chemical_classification0303 health sciencesMetalloproteinaseProteaseBase SequenceNeurodegenerationTioproninBrainCell BiologyTerminal amine isotopic labeling of substratesmedicine.diseaseIn vitroRecombinant Proteins3. Good healthMice Inbred C57BLEnzymechemistryBiochemistryProtein Synthesis and Degradationbiology.protein030217 neurology & neurosurgeryThe Journal of biological chemistry
researchProduct

Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6

1998

A human antibody library was displayed on the surface of filamentous bacteriophage and screened for binding to human interleukin-6 (IL-6). Two antibody-bearing phages were selected that bound IL-6. The complementary-determining region 3 loops of the variable heavy chains of these two antibodies differed in length and sequence and recognized two distinct epitopes. One of the single chain Fv fragments isolated (H1) was found to bind human (but not murine) IL-6 with an affinity comparable to that of the human IL-6 receptor. H1 also recognized newly synthesized human IL-6 intracellularly, as shown by indirect immunofluorescence. H1 did not neutralize human IL-6, and the H1 epitope was mapped to…

medicine.medical_treatmentCell BiologySingle-Chain FvBiologyGlycoprotein 130biology.organism_classificationBiochemistryMolecular biologyEpitopelaw.inventionCytokineFilamentous bacteriophagelawmedicinebiology.proteinRecombinant DNAAntibodyReceptorMolecular BiologyJournal of Biological Chemistry
researchProduct

Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time…

2010

5 páginas, 3 figuras.

medicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationHematopoietic stem cell transplantationBiologyPolymerase Chain ReactionAutomationPlasmaVirologymedicineHumansViral loadHematopoietic Stem Cell Transplantationvirus diseasesViral LoadUniversity hospitalmedicine.diseaseVirologyDNA extractionAllogeneic stem cell transplantReverse transcription polymerase chain reactionInfectious DiseasesReal-time polymerase chain reactionSpainImmunologyCytomegalovirus InfectionsAllogeneic hematopoietic stem cell transplantViral loadReal-time PCRJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology
researchProduct

Erythritol-enriched powder and oral biofilm regrowth on dental implants: an in vitro study.

2021

Background Peri-implant mucositis and peri-implantitis are the main biological complications associated with dental implants. Since most authors agree that bacteria play a major etiological role, the main aims of this study were to determine if a formulation of erythritol and chlorhexidine applied with an air polishing system inhibits biofilm regrowth over dental implants and to compare the decontamination capacity of this therapy with that of mechanical removal by saline and gauze. Material and Methods A multispecies biofilm (P. gingivalis, A. actinomycetemcomitans, F. nucleatum, A. naeslundii, V. parvula and S. oralis) was grown for 14 days on 52 dental implants in an artificial mouth. Th…

medicine.medical_treatmentDentistryComplications (Medicine)Erythritolchemistry.chemical_compoundPropidium monoazidemedicineMucositisHumansimplantoplastytitaniumGeneral DentistrySalineUNESCO:CIENCIAS MÉDICASDental ImplantsbiologyImplants dentalsChemistrybusiness.industryResearchChlorhexidineDental implantsBiofilmAggregatibacter actinomycetemcomitansmedicine.diseasebiology.organism_classificationcompressive strengthPeri-ImplantitisErythritolComplicacions (Medicina)OtorhinolaryngologyBiofilmsSurgeryPowdersbusinessImplantologyBacteriamedicine.drug
researchProduct

The Potential Use of Resveratrol for Cancer Prevention.

2019

In addition to the traditional treatments of cancer and cancer prevention, the use of natural compounds, especially those found in food, should be considered. To clarify if resveratrol has the potential for cancer prevention and the possibility of use in therapy, the following must be taken into account: data from epidemiology, clinical protocol (case and control), preclinical studies (lab animals), use of established cell lines as models of cancer cells, test tube assays (enzymes activities), and requirements of nanotechnologies in order to discover new drugs to fight cancer. From this perspective and future expected advances, more information is needed such as improved efficacy, methods o…

medicine.medical_treatmentDrug Evaluation PreclinicalPharmaceutical ScienceReviewResveratrolresveratrolBioinformaticsChemopreventionAnalytical Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinepreventionNeoplasmsDrug DiscoverymedicineAnimalsHumanscancerPhysical and Theoretical ChemistrySensitization030304 developmental biology0303 health sciencesmechanismsCancer preventionbusiness.industryOrganic ChemistryClinical Studies as TopicCancerDisease Managementmedicine.diseaseAntineoplastic Agents PhytogenicBioavailabilitymedicine.anatomical_structurechemistryChemistry (miscellaneous)030220 oncology & carcinogenesisapproach strategiesCancer cellMolecular MedicineDisease Susceptibilitybusinessinnovative formulationsAdjuvantSignal TransductionMolecules (Basel, Switzerland)
researchProduct

Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man.

2002

Mutations and aberrant expression of the p53 tumor suppressor protein are the most frequent molecular alterations in human malignancy. Peptides derived from the wild-type (wt) p53 protein and presented by major histocompatibility complex (MHC) molecules for T lymphocyte recognition are believed to serve as universal tumor-associated antigens for cancer immunotherapy. We studied the immunogeneicity of a recombinant replication-defective adenoviral vector encoding human full-length wt p53 (rAd/hup53) in human leukocyte antigen (HLA)-A2K(b)-transgenic (Tg) mice and man. The generation of p53 epitope-specific cytotoxic T lymphocytes (CTLs) in p53-proficient and p53-deficient A2K(b)-Tg mice was …

medicine.medical_treatmentGenetic VectorsEpitopes T-LymphocyteMice TransgenicPilot ProjectsHuman leukocyte antigenBiologyMajor histocompatibility complexCancer VaccinesEpitopeAdenoviridaeMiceImmune systemCancer immunotherapyAntigenSpecies SpecificityNeoplasmsHLA-A2 AntigenGeneticsmedicineCytotoxic T cellAnimalsHumansTreatment FailureMolecular BiologyT lymphocyteGenetic TherapyGenes p53Self ToleranceImmunologybiology.proteinMolecular MedicineTumor Suppressor Protein p53T-Lymphocytes CytotoxicGene therapy
researchProduct

Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation

2014

Graft-versus-host disease (GVHD) is a frequent life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT) and induced by donor-derived T cells that become activated by host antigen-presenting cells. To address the relevance of host dendritic cell (DC) populations in this disease, we used mouse strains deficient in CD11c(+) or CD8α(+) DC populations in a model of acute GVHD where bone marrow and T cells from BALB/c donors were transplanted into C57BL/6 hosts. Surprisingly, a strong increase in GVHD-related mortality was observed in the absence of CD11c(+) cells. Likewise, Batf3-deficient (Batf3(-/-)) mice that lack CD8α(+) DCs also displayed a strongly incr…

medicine.medical_treatmentGraft vs Host DiseasePriming (immunology)CD11cHematopoietic stem cell transplantationchemical and pharmacologic phenomenaHematopoietic stem cell transplantationCD8-Positive T-LymphocytesBiologyGraft-versus-host diseaseDendritic cellsMiceimmune system diseasesBATF3medicineAnimalsTransplantation HomologousBone Marrow TransplantationMice Inbred BALB CTransplantationPeripheral toleranceHematologyDendritic cellmedicine.diseaseMice Inbred C57BLsurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureImmunologyBone marrowCD8Biology of Blood and Marrow Transplantation
researchProduct

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

2001

We identified a tumor-associated cytotoxic T lymphocyte (CTL) epitope derived from the widely expressed human MDM2 oncoprotein and were able to bypass self-tolerance to this tumor antigen in HLA-A*0201 (A2.1) transgenic mice and by generating A2.1-negative, allo-A2.1-restricted human T lymphocytes. A broad range of malignant, as opposed to nontransformed cells, were killed by high-avidity transgenic mouse and allogeneic human CTLs specific for the A2.1-presented MDM2 epitope. Whereas the self-A2.1-restricted human T cell repertoire gave rise only to low-avidity CTLs unable to recognize the natural MDM2 peptide, human A2.1+ T lymphocytes were turned into efficient MDM2-specific CTLs upon exp…

medicine.medical_treatmentImmunologyT-cell receptorchemical and pharmacologic phenomenaImmunotherapyBiologyMajor histocompatibility complexMolecular biologyTumor antigenEpitopeCTL*Antigenmedicinebiology.proteinImmunology and AllergyCytotoxic T cell
researchProduct

An unconventional TRAIL to cancer therapy

2013

Cellular immunotherapy offers novel, safe, and effective routes to treating cancer. However, approaches utilizing cytotoxic CD8+ T cells are hampered by the need to identify suitable target antigens that are expressed by tumor cells but not healthy tissues, and that are recognized with sufficient affinity. Most importantly, the applicability of CD8+ T-cell-based therapies is governed by the MHC restriction of tumor-specific epitopes, thereby limiting the potential benefit to patients carrying the appropriate MHC haplotype. Alternative approaches to harness the immune system against tumors exploit non-MHC-restricted γδ T cells that recognize stress-induced changes in transformed cells. A new…

medicine.medical_treatmentImmunologychemical and pharmacologic phenomenaImmunotherapyMHC restrictionBiologyNKG2DMajor histocompatibility complexEpitopeImmune systemAntigenImmunologymedicinebiology.proteinImmunology and AllergyCytotoxic T cellEuropean Journal of Immunology
researchProduct

Supraglottic airway devices for surfactant treatment: systematic review and meta-analysis

2019

Objective: To compare surfactant administration via supraglottic airway device (SAD) vs. nasal CPAP alone or INSURE. Study design: A systematic search of PubMed, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials and Clinicaltrials.gov was performed. Articles meeting inclusion criteria (RCT, surfactant administration via SAD, laryngeal mask, I-gel) were assessed Results: Five RCTs were eligible. Surfactant administration via SAD reduced the need for intubation/mechanical ventilation (RR 0.57, 95%CI 0.38–0.85) and short-term oxygen requirements (MD −8.00, 95%CI −11.09 to −4.91) compared to nCPAP alone. Surfactant administration via SAD reduced the need for intubation/mechanical v…

medicine.medical_treatmentLaryngeal Maskslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPulmonary surfactantlaw030225 pediatricsmedicineIntubation IntratrachealIntubationHumans030212 general & internal medicineRandomized Controlled Trials as TopicMechanical ventilationSupraglottic airwayRespiratory Distress Syndrome Newbornbusiness.industryInfant NewbornObstetrics and GynecologyPulmonary SurfactantsSupraglottic airwayRespiration ArtificialClinical trialLaryngeal MasksMeta-analysisAnesthesiaPediatrics Perinatology and Child Healthsurfactant treatmentbusinessInfant Premature
researchProduct